» Articles » PMID: 28696210

Role of Chromosomal Instability in Cancer Progression

Overview
Specialties Endocrinology
Oncology
Date 2017 Jul 12
PMID 28696210
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells often display (CIN), a defect that involves loss or rearrangement of the cell's genetic material - chromosomes - during cell division. This process results in the generation of aneuploidy, a deviation from the haploid number of chromosomes, and structural alterations of chromosomes in over 90% of solid tumours and many haematological cancers. This trait is unique to cancer cells as normal cells in the body generally strictly maintain the correct number and structure of chromosomes. This key difference between cancer and normal cells has led to two important hypotheses: (i) cancer cells have had to overcome inherent barriers to changes in chromosomes that are not tolerated in non-cancer cells and (ii) CIN represents a cancer-specific target to allow the specific elimination of cancer cells from the body. To exploit these hypotheses and design novel approaches to treat cancer, a full understanding of the mechanisms driving CIN and how CIN contributes to cancer progression is required. Here, we will discuss the possible mechanisms driving chromosomal instability, how CIN may contribute to the progression at multiple stages of tumour evolution and possible future therapeutic directions based on targeting cancer chromosomal instability.

Citing Articles

Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma.

Nie A, Xiao Z, Deng J, Li N, Hao L, Li S World J Gastrointest Oncol. 2025; 17(2):98556.

PMID: 39958554 PMC: 11755995. DOI: 10.4251/wjgo.v17.i2.98556.


Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons.

Ibrahim S, Khan M, Khurram I, Rehman R, Rauf A, Ahmad Z Food Sci Nutr. 2025; 13(2):e70011.

PMID: 39898116 PMC: 11786021. DOI: 10.1002/fsn3.70011.


Tumour hypoxia in driving genomic instability and tumour evolution.

Suvac A, Ashton J, Bristow R Nat Rev Cancer. 2025; 25(3):167-188.

PMID: 39875616 DOI: 10.1038/s41568-024-00781-9.


Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis.

Karami Fath M, Nazari A, Parsania N, Behboodi P, Ketabi S, Razmjouei P Med Oncol. 2024; 41(11):254.

PMID: 39352464 DOI: 10.1007/s12032-024-02524-0.


Research advances in the molecular classification of gastric cancer.

Shi D, Yang Z, Cai Y, Li H, Lin L, Wu D Cell Oncol (Dordr). 2024; 47(5):1523-1536.

PMID: 38717722 PMC: 11466988. DOI: 10.1007/s13402-024-00951-9.